Aterian, Inc. (NASDAQ:ATER) Short Interest Up 96.5% in January

Aterian, Inc. (NASDAQ:ATERGet Free Report) was the recipient of a significant growth in short interest in January. As of January 30th, there was short interest totaling 291,202 shares, a growth of 96.5% from the January 15th total of 148,224 shares. Approximately 3.6% of the company’s stock are short sold. Based on an average trading volume of 113,257 shares, the short-interest ratio is currently 2.6 days. Based on an average trading volume of 113,257 shares, the short-interest ratio is currently 2.6 days. Approximately 3.6% of the company’s stock are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Aterian in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Aterian has an average rating of “Reduce” and a consensus price target of $4.00.

Read Our Latest Stock Analysis on Aterian

Institutional Trading of Aterian

A number of institutional investors have recently made changes to their positions in ATER. Goldman Sachs Group Inc. boosted its holdings in shares of Aterian by 73.0% in the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after acquiring an additional 9,026 shares in the last quarter. XTX Topco Ltd bought a new stake in Aterian during the second quarter worth approximately $55,000. Citadel Advisors LLC lifted its position in Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after purchasing an additional 22,865 shares during the period. Ground Swell Capital LLC bought a new position in Aterian during the 2nd quarter valued at $58,000. Finally, Susquehanna International Group LLP boosted its stake in Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after purchasing an additional 30,637 shares in the last quarter. 7.02% of the stock is owned by institutional investors and hedge funds.

Aterian Price Performance

Shares of Aterian stock opened at $0.65 on Friday. Aterian has a 1-year low of $0.62 and a 1-year high of $3.50. The business’s fifty day moving average price is $0.74 and its two-hundred day moving average price is $0.90. The company has a market capitalization of $6.47 million, a P/E ratio of -0.40 and a beta of 0.11.

Aterian (NASDAQ:ATERGet Free Report) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($0.28) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.63) by $0.35. The business had revenue of $19.02 million for the quarter, compared to analysts’ expectations of $19.88 million. Aterian had a negative net margin of 15.73% and a negative return on equity of 47.45%.

Aterian Company Profile

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

Recommended Stories

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.